Jo Raskin

10PUBLICATIONS
41CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMedical mycologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 18, 2026
Differentiating benign and malignant solitary pulmonary nodules through exhaled breath analysis.

Kathleen Zwijsen, Reinier R L Wener, Ellen Heirwegh

|Jun 06, 2024
A randomised phase II study of extended pleurectomy/decortication preceded or followed by chemotherapy in patients with early-stage pleural mesothelioma: EORTC 1205.

Jo Raskin, Veerle Surmont, Alexander P W M Maat

|Jul 27, 2022
New Implications of Patients' Sex in Today's Lung Cancer Management.

Jo Raskin, Annemiek Snoeckx, Annelies Janssens

|Jul 09, 2022
External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma.

Eline Janssens, Eline Schillebeeckx, Kathleen Zwijsen

|Mar 25, 2022
Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma.

Sophie Rovers, Annelies Janssens, Jo Raskin

|Dec 17, 2021
INSIGHT 2: a phase II study of tepotinib plus osimertinib in MET-amplified NSCLC and first-line osimertinib resistance.

Egbert F Smit, Christophe Dooms, Jo Raskin

Pageof 2

Frequent Collaborators

3 joint publications

Evelien Smits

2 joint publications

Annelies Janssens

2 joint publications

Elly Marcq

2 joint publications

Julien Mazieres